Srs Capital Advisors, Inc. Biotechnology

Srs Capital Advisors, Inc.

$1.07 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
INZY Inozyme Pharma, Inc.	$116M	$2,000 0.0% of portfolio	475	Q2 2024 New
VYGR Voyager Therapeutics, Inc.	$208M	$2,000 0.0% of portfolio	411	Q2 2024 New
SWTX Spring Works Therapeutics, Inc.	$2.37B	$2,000 0.0% of portfolio	75	Q3 2024 Reduced 7.41%
OCUL Ocular Therapeutix, Inc	$669M	$2,000 0.0% of portfolio	274	Q2 2024 New
CARA Cara Therapeutics, Inc.	$15.6M	$2,000 0.0% of portfolio	7,571	Q2 2024 Added 4.07%
THRD Third Harmonic Bio, Inc.	$490M	$2,000 0.0% of portfolio	171	Q2 2024 New
ERAS Erasca, Inc.	$333M	$2,000 0.0% of portfolio	846	Q2 2024 New
STRO Sutro Biopharma, Inc.	$143M	$2,000 0.0% of portfolio	657	Q2 2024 New
IBRX Immunity Bio, Inc.	$2.14B	$2,000 0.0% of portfolio	608	Q3 2024 Reduced 27.96%
HRTX Heron Therapeutics, Inc.	$139M	$2,000 0.0% of portfolio	1,095	Q2 2024 New
INSM Insmed Inc	$9.99B	$1,000 0.0% of portfolio	27	Q3 2024 Added 50.0%
LRMR Larimar Therapeutics, Inc.	$269M	$1,000 0.0% of portfolio	286	Q2 2024 New
HALO Halozyme Therapeutics, Inc.	$6.24B	$1,000 0.0% of portfolio	29	Q3 2024 Reduced 3.33%
CELC Celcuity Inc.	$186M	$1,000 0.0% of portfolio	104	Q2 2024 New
FGEN Fibrogen Inc	$31.9M	$1,000 0.0% of portfolio	3,681	Q2 2024 New
ALDX Aldeyra Therapeutics, Inc.	$274M	$1,000 0.0% of portfolio	266	Q2 2024 New
RVMD Revolution Medicines, Inc.	$4.95B	$1,000 0.0% of portfolio	31	Q2 2024 New
TVTX Travere Therapeutics, Inc.	$1.12B	$1,000 0.0% of portfolio	97	Q2 2024 New
ENTA Enanta Pharmaceuticals Inc	$198M	$1,000 0.0% of portfolio	128	Q2 2024 New
DSGN Design Therapeutics, Inc.	$321M	$1,000 0.0% of portfolio	244	Q2 2024 New
CDXS Codexis, Inc.	$257M	$1,000 0.0% of portfolio	424	Q2 2024 New
GLPG Galapagos Nv	$1.76B	$1,000 0.0% of portfolio	40	Q3 2024 New
KRYS Krystal Biotech, Inc.	$4.56B	$1,000 0.0% of portfolio	6	Q3 2024 New
LQDA Liquidia Corp	$632M	$1,000 0.0% of portfolio	109	Q2 2024 New
ARGX Argenx Se	$31.8B	$1,000 0.0% of portfolio	2	Q3 2023 New
ENLV Enlivex Therapeutics Ltd.	$19.3M	$1,000 0.0% of portfolio	615	Q2 2024 New
ROIV Roivant Sciences Ltd.	$7.97B	$1,000 0.0% of portfolio	88	Q3 2024 New
FOLD Amicus Therapeutics, Inc.	$2.67B	$1,000 0.0% of portfolio	94	Q3 2024 New
LXRX Lexicon Pharmaceuticals, Inc.	$170M	$1,000 0.0% of portfolio	639	Q2 2024 New
VRCA Verrica Pharmaceuticals Inc.	$327M	$1,000 0.0% of portfolio	241	Q2 2024 New
RVNC Revance Therapeutics, Inc.	$212M	$0 0.0% of portfolio	209	Q2 2024 New
AXSM Axsome Therapeutics, Inc.	$4.09B	$0 0.0% of portfolio	11	Q3 2024 New
ITOS I Teos Therapeutics, Inc.	$280M	$0 0.0% of portfolio	95	Q2 2024 New
KROS Keros Therapeutics, Inc.	$1.39B	$0 0.0% of portfolio	16	Q2 2024 New
NKTX Nkarta, Inc.	$121M	$0 0.0% of portfolio	204	Q2 2024 New
BGNE Bei Gene, Ltd.	$19.5B	$0 0.0% of portfolio	4	Q3 2024 Reduced 42.86%
GERN Geron Corp	$1.43B	$0 0.0% of portfolio	198	Q3 2024 Reduced 59.34%
BMRN Biomarin Pharmaceutical Inc	$11.5B	$0 0.0% of portfolio	12	Q3 2024 Added 33.33%
MNKD Mannkind Corp	$1.73B	$0 0.0% of portfolio	134	Q2 2024 New
ALT Altimmune, Inc.	$351M	$0 0.0% of portfolio	133	Q2 2024 New
TRDA Entrada Therapeutics, Inc.	$557M	$0 0.0% of portfolio	45	Q2 2024 New
OMER Omeros Corp	$371M	$0 0.0% of portfolio	180	Q2 2024 New
URGN Uro Gen Pharma Ltd.	$251M	$0 0.0% of portfolio	56	Q2 2024 New
SAGE Sage Therapeutics, Inc.	$292M	$0 0.0% of portfolio	97	Q2 2024 New
ACAD Acadia Pharmaceuticals Inc	$2.62B	$0 0.0% of portfolio	44	Q2 2024 New
PGEN Precigen, Inc.	$164M	$0 0.0% of portfolio	690	Q2 2024 New
PEPG Pep Gen Inc.	$106M	$0 0.0% of portfolio	76	Q2 2024 New
VCYT Veracyte, Inc.	$2.8B	$0 0.0% of portfolio	19	Q3 2024 Reduced 44.12%
SANA Sana Biotechnology, Inc.	$449M	$0 0.0% of portfolio	150	Q2 2024 New
KMPH Kempharm, Inc	$170M	$0 0.0% of portfolio	87	Q2 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.